Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Other Benefit Plans (Tables)

v3.20.1
Stock-Based Compensation and Other Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2020
Stock-Based Compensation and Other Benefit Plans [Abstract]  
Summary of Stock-Based Compensation

Three Months Ended March 31,

2020

2019

(in thousands)

Stock-based compensation - equity awards

$

145

$

27

Stock-based compensation - liability awards

(2,714)

1,696

Total stock-based compensation

$

(2,569)

$

1,723

Stock Option Valuation Assumptions

Three Months Ended March 31,

2020

2019

Weighted average exercise price - ($/share)

N/A

$

1.58

Expected life in years

N/A

3.5

Average expected volatility

N/A

72.93

%

Risk-free interest rate

N/A

2.52

%

Weighted average grant date fair value - ($/share)

N/A

$

1.23

Stock Option Activity

Number of Shares Underlying Options

Weighted Average Exercise Price Per Share

Weighted Average Remaining Contractual Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2020

2,834

$

1.55

Granted

Exercised

Unvested shares forfeited

Vested shares expired

(120)

4.98

Outstanding at March 31, 2020

2,714

1.39

2.64

$

17

Exercisable at March 31, 2020

2,043

1.28

2.42

$

11

Summary of Non Vested Awards

Restricted Stock

Weighted Average Grant Price

(in thousands)

Non-vested shares outstanding at January 1, 2020

343

$

1.52

Awards granted

Awards vested

(125)

1.37

Awards forfeited

Non-vested shares outstanding at March 31, 2020

218

1.61

SAR Activity

Number of Shares Underlying SARs

Weighted Average Exercise Price Per Share

Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2020

3,418

$

1.30

Granted

Exercised

Unvested shares forfeited

Vested shares expired

Outstanding at March 31, 2020

3,418

1.30

2.96

$

73

Exercisable at March 31, 2020

1,813

1.13

2.74

$

47